Apoptosis induction by arsenic: mechanisms of action and possible clinical applications for treating therapy-resistant cancers

This publication has 65 references indexed in Scilit:

• Phenylarsine Oxide Blocks Interleukin-1β–Induced Activation of the Nuclear Transcription Factor NF-κB, Inhibits Proliferation, and Induces Apoptosis of Acute Myelogenous Leukemia Cells
  Blood, 1999
• Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia
  Annals of Hematology, 1999
• Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemia
  Bone Marrow Transplantation, 1999
• The enigma of arsenic carcinogenesis: role of metabolism
  Toxicological Sciences, 1999
• Carcinogenicity of metal compounds: possible role of DNA repair inhibition
  Toxicology Letters, 1998
• Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
  New England Journal of Medicine, 1998
• Arsenic Trioxide in the Treatment of a Patient with Multiply Recurrent, ATRA-Resistant Promyelocytic Leukemia
  Journal of Pediatric Hematology/Oncology, 1998
• Comparative Activity of Melarsoprol and Arsenic Trioxide in Chronic B-Cell Leukemia Lines
  Blood, 1997
• New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation
  Cancer Chemotherapy and Pharmacology, 1997
• In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins
  Blood, 1996